The RMDN1 gene helps mitochondria, the parts of cells that make energy, build some of the proteins they need. When both copies do not work properly, the body may struggle to make enough energy, especially in the brain, muscles, kidneys, and inner ear. People with severe variants in the RMDN1 gene can develop a rare inherited mitochondrial condition with developmental delay, hearing loss, muscle weakness, feeding problems, or kidney disease.

What is a gene?

Genes are sections of DNA that give your cells instructions for making molecules or regulating activities in the body. Some carry the code for proteins, which do much of the work inside cells. Others mainly direct when certain processes happen, where they happen, and how active they are. Taken together, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.

Overview

RMDN1

Gene function

What if the gene works

The RMDN1 gene helps keep mitochondria working well by supporting contact between mitochondria and the endoplasmic reticulum, another cell structure. This helps cells manage energy and calcium, especially in tissues with high energy needs.

Risk

What if the gene does not work

People with disease-causing variants in the RMDN1 gene can develop a mitochondrial condition that often affects developmental progress, hearing, movement, and growth. Effects range from milder to more severe, and some may also have kidney problems or raised lactic acid.

Treatment

What does that mean for your treatment

No RMDN1-specific treatment or drug-selection approach is currently established for people with a pathogenic or loss-of-function variant in the RMDN1 gene. Care is based on the person’s symptoms and general management of mitochondrial disease, rather than a treatment chosen specifically for the RMDN1 gene.

Gene function

What if the gene works

Your cells need a steady energy supply to keep muscles moving, nerves signaling, and organs working. The RMDN1 gene supports mitochondria, the parts of cells that make most of that energy, by helping them build key proteins and stay organized. When this gene is working normally, mitochondria can carry out these routine jobs more smoothly.

Protein building

Inside mitochondria, the RMDN1 gene helps make a small set of proteins needed for mitochondrial energy production. This gives the cell’s energy system the parts it needs to work steadily.

Mitochondria placement

The RMDN1 gene also helps keep mitochondria arranged within the cell by linking them to the cell’s internal support tracks. Good placement helps energy reach the areas of the cell that need it most.

What is a variant?

A genetic variant is a minor difference in the DNA sequence within a gene. Variants like these are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not lead to any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works to a greater extent and can contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the RMDN1 gene can make the RMDN1 protein unstable, misshapen, or too scarce, which may disrupt key contacts inside the cell and reduce mitochondrial energy production. In practical terms, how variants influence the RMDN1 gene's function depends on how much protein activity remains. Milder variants may leave some function, while more severe variants can cause little to no activity and are often linked to earlier or more noticeable features of the associated mitochondrial condition.

How variants are linked to conditions

RMDN1 does not yet have a broadly confirmed link to a specific health condition, though this may change as research develops. Current evidence on how RMDN1 gene variants are linked to conditions remains limited, so any confirmed result is best interpreted with a doctor or genetic counselor who can place it in the full clinical context.

A variant is not necessarily a diagnosis

Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RMDN1 gene. For many living with an RMDN1 change, risk depends mainly on the exact variant and family history rather than clear lifestyle factors, and a doctor or genetic counselor can help explain personal risk.

Inheritance of RMDN1 variants

RMDN1 gene inheritance is usually autosomal recessive for the condition currently linked to pathogenic variants in this gene. This means a child typically inherits one altered copy of the RMDN1 gene from each parent, and the parents are often healthy carriers. When both parents carry a pathogenic variant, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variant. Because the RMDN1 gene is on chromosome 6, this pattern is the same for males and females.

What does my RMDN1 result mean for my family?

For families with a disease-causing change in the RMDN1 gene, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters may also be carriers or, less often, affected. Close relatives may want to learn whether the same change runs in the family, especially when there is a history of early severe illness in children. The main family question is often whether future children could inherit the condition.


Genetic information


Genetic testing

How you find out about variants

RMDN1 genetic testing looks for variants in the RMDN1 gene using a blood sample, saliva sample, or sometimes a cheek swab. A lab reads the gene as part of a single gene test, a broader panel, or exome sequencing, which can help confirm whether a condition linked to the RMDN1 gene is present.

When should I consider getting a genetic test?

Genetic testing for the RMDN1 gene may be considered when a baby or child has signs of a rare inherited condition that affects how the body makes energy, such as developmental delay, hearing loss, muscle weakness, feeding problems, or repeated high lactic acid levels. It can also help when similar problems run in the family.

A genetic result is only one part of your health story

Genetic test results can provide meaningful information, but how much they reveal depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can help put individual experiences into perspective.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how your body handles some medicines, so the same treatment may work a bit differently from one person to another. These inherited differences can change how quickly a drug is broken down, how much reaches its target, or how sensitive the body is to its effects. This kind of variation is common and can influence both how well a treatment works and the chance of side effects.

What is Pharmacogenetics?

Pharmacogenetics is the study of how genetic differences affect response to medications. It examines relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how the body processes a drug or how strongly it acts. This information can support more informed, more individualized treatment decisions. To explore this subject further, you can find more in the LearnHub.


Drugs influenced by the RMDN1 gene

There are 0 Drugs associated with RMDN1
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in guiding medication response. If you have questions about side effects, how well a medicine is working, or how your health condition may affect treatment, talk with your doctor.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved